Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GENSET/GENETHON JOINT VENTURE FOR HUMAN GENOME SEQUENCING

Executive Summary

GENSET/GENETHON JOINT VENTURE FOR HUMAN GENOME SEQUENCING will give Paris-based Genset commercial rights to any applications arising from efforts to sequence and analyze the regulatory regions of the human genome. The agreement, announced June 29, calls for Genset and the French research center Genethon to form the Tres Grand Sequencage laboratory that will be funded by an initial commitment of $11 mil. from both parties, including a $2 million equity participation in Genset made by Genethon.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024702

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel